Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
2.060
-0.060 (-2.83%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Jin Medical International Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 19.73 | 20.69 | 23.5 | 19.82 | 19.19 | 20.76 | |
Revenue Growth | -13.59% | -11.98% | 18.57% | 3.29% | -7.58% | 28.22% |
Cost of Revenue | 13.55 | 14.44 | 13.89 | 12.86 | 12.83 | 14.18 |
Gross Profit | 6.17 | 6.24 | 9.61 | 6.96 | 6.36 | 6.59 |
Selling, General & Admin | 3.84 | 3.88 | 4.37 | 2.37 | 2.18 | 2.16 |
Research & Development | 1.78 | 1.56 | 1.5 | 1.54 | 1.89 | 1.57 |
Other Operating Expenses | 0.13 | 0.2 | 0.11 | 0.18 | 0.16 | 0.23 |
Operating Expenses | 5.75 | 5.63 | 5.97 | 4.1 | 4.23 | 3.95 |
Operating Income | 0.42 | 0.61 | 3.64 | 2.87 | 2.13 | 2.63 |
Interest Expense | - | - | - | - | - | -0.01 |
Interest & Investment Income | 0.53 | 0.79 | 0.47 | 0.18 | 0.18 | - |
Currency Exchange Gain (Loss) | -0.28 | 0.02 | -0.03 | -0.05 | 0.19 | 0.06 |
Other Non Operating Income (Expenses) | 0.6 | 0.18 | 0.11 | 0.22 | 0.24 | 0.19 |
Pretax Income | 1.26 | 1.6 | 4.18 | 3.22 | 2.74 | 2.88 |
Income Tax Expense | 0.1 | 0.21 | 0.76 | 0.34 | 0.04 | 0.25 |
Earnings From Continuing Operations | 1.16 | 1.38 | 3.42 | 2.88 | 2.71 | 2.63 |
Minority Interest in Earnings | 0.01 | -0.19 | 0.26 | - | - | - |
Net Income | 1.17 | 1.19 | 3.68 | 2.88 | 2.71 | 2.63 |
Net Income to Common | 1.17 | 1.19 | 3.68 | 2.88 | 2.71 | 2.63 |
Net Income Growth | -34.60% | -67.59% | 27.71% | 6.34% | 2.84% | 19.30% |
Shares Outstanding (Basic) | 8 | 8 | 8 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 7 | 7 | 7 |
Shares Change | - | 0.05% | 7.81% | 7.51% | - | -66.25% |
EPS (Basic) | 0.15 | 0.15 | 0.47 | 0.40 | 0.40 | 0.39 |
EPS (Diluted) | 0.15 | 0.15 | 0.47 | 0.40 | 0.40 | 0.39 |
EPS Growth | -34.60% | -67.61% | 18.46% | -1.08% | 2.84% | 253.48% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -6.96 | -3.73 | -1.35 | 2.99 | 1.54 | 5.8 |
Free Cash Flow Per Share | -0.89 | -0.48 | -0.17 | 0.41 | 0.23 | 0.86 |
Gross Margin | 31.28% | 30.18% | 40.89% | 35.14% | 33.13% | 31.72% |
Operating Margin | 2.12% | 2.94% | 15.48% | 14.46% | 11.10% | 12.67% |
Profit Margin | 5.95% | 5.76% | 15.64% | 14.52% | 14.10% | 12.67% |
Free Cash Flow Margin | -35.28% | -18.01% | -5.75% | 15.10% | 8.03% | 27.93% |
EBITDA | 0.66 | 0.85 | 3.88 | 3.09 | 2.49 | 2.98 |
EBITDA Margin | 3.33% | 4.12% | 16.50% | 15.60% | 12.99% | 14.34% |
D&A For EBITDA | 0.24 | 0.24 | 0.24 | 0.23 | 0.36 | 0.35 |
EBIT | 0.42 | 0.61 | 3.64 | 2.87 | 2.13 | 2.63 |
EBIT Margin | 2.12% | 2.94% | 15.48% | 14.46% | 11.10% | 12.67% |
Effective Tax Rate | 7.84% | 13.45% | 18.26% | 10.67% | 1.32% | 8.63% |
Revenue as Reported | 19.73 | 20.69 | 23.5 | 19.82 | 19.19 | 20.76 |